Following the acquisition of Paige in 2025, Tempus launches its new AI-powered, biomarker prediction solution for digital ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
Tempus AI's diagnostics segment shows strong pricing power, with Oncology ASP rising from $1,630 to over $2,200. Read why TEM ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
Detailed price information for GE Healthcare Technologies Inc (GEHC-Q) from The Globe and Mail including charting and trades.
Chicago artificial intelligence giant Tempus AI is showing it's operating in the black after 10 years and growing.
In smaller moves, ARK sold 2,631 shares of Kratos Defense and Security Solutions Inc (NASDAQ:KTOS) across three ETFs for $317,272, and purchased 7,175 shares of Kodiak AI Inc (KDK) through its ARKQ ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, will participate in the 44th Annual J.P. Morgan Healthcare Conference, taking place ...
Northwestern Medicine and Tempus AI, Inc. (NASDAQ: TEM) are collaborating to expand access to genomic testing for ...
Tempus AI stock remains in a bear market after crashing by 36% from its highest point in September last year. What next for ...
Digital health company Rune Labs, which helps people with Parkinson’s disease track their symptoms, said Thursday that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results